These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32223791)

  • 1. Pregabalin-induced sexual disinhibition.
    Murphy R; McGuinness D; Hallahan B
    Ir J Psychol Med; 2020 Mar; 37(1):55-58. PubMed ID: 32223791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregabalin in acute treatment of anxious depression: a case series.
    Anderson C; George D; Quante A
    Psychiatry Res; 2014 Jan; 215(1):246-8. PubMed ID: 24611161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological rationale and potential clinical use of gabapentin and pregabalin in bipolar disorder, insomnia and anxiety: protocol for a systematic review and meta-analysis.
    Houghton KT; Forrest A; Awad A; Atkinson LZ; Stockton S; Harrison PJ; Geddes JR; Cipriani A
    BMJ Open; 2017 Mar; 7(3):e013433. PubMed ID: 28348186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregabalin: dose-response relationship in generalized anxiety disorder.
    Boschen MJ
    Pharmacopsychiatry; 2012 Mar; 45(2):51-6. PubMed ID: 22086745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice.
    Ruiz MA; Álvarez E; Carrasco JL; Olivares JM; Pérez M; Rejas J
    Drug Des Devel Ther; 2015; 9():4329-40. PubMed ID: 26273194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder.
    Kasper S; Iglesias-García C; Schweizer E; Wilson J; DuBrava S; Prieto R; Pitman VW; Knapp L
    Int J Neuropsychopharmacol; 2014 May; 17(5):685-95. PubMed ID: 24351233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin for anxiety in patients with schizophrenia - A randomized, double-blind placebo-controlled study.
    Schjerning O; Damkier P; Lykkegaard SE; Jakobsen KD; Nielsen J
    Schizophr Res; 2018 May; 195():260-266. PubMed ID: 28919128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety.
    Owen RT
    Drugs Today (Barc); 2007 Sep; 43(9):601-10. PubMed ID: 17940637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder.
    Buoli M; Caldiroli A; Serati M
    Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):351-359. PubMed ID: 28075650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of the efficacy of pregabalin in the treatment of generalized anxiety disorder.
    Boschen MJ
    Can J Psychiatry; 2011 Sep; 56(9):558-66. PubMed ID: 21959031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin dependence: a case report.
    Halaby A; Kassm SA; Naja WJ
    Curr Drug Saf; 2015; 10(2):184-6. PubMed ID: 25336156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin and Pregabalin for the Treatment of Anxiety Disorders.
    Greenblatt HK; Greenblatt DJ
    Clin Pharmacol Drug Dev; 2018 Mar; 7(3):228-232. PubMed ID: 29579375
    [No Abstract]   [Full Text] [Related]  

  • 13. Sexual Dysfunctions Induced by Pregabalin.
    Hamed SA
    Clin Neuropharmacol; 2018; 41(4):116-122. PubMed ID: 30001248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pregabalin can cause addiction and withdrawal symptoms].
    Nordgaard J; Jürgens G
    Ugeskr Laeger; 2015 Jan; 177(2A):38-9. PubMed ID: 25612958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregabalin: a new anxiolytic.
    Lauria-Horner BA; Pohl RB
    Expert Opin Investig Drugs; 2003 Apr; 12(4):663-72. PubMed ID: 12665421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model.
    Nutt D; Mandel F; Baldinetti F
    J Psychopharmacol; 2009 Nov; 23(8):867-73. PubMed ID: 18635690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin for the treatment of generalised anxiety disorder.
    Montgomery SA
    Expert Opin Pharmacother; 2006 Oct; 7(15):2139-54. PubMed ID: 17020438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin in Tourette's Syndrome: A Case Series.
    Hienert M; Weidenauer A; Kraus C; Willeit M; Kasper S; Stamenkovic M
    Am J Psychiatry; 2016 Dec; 173(12):1242-1243. PubMed ID: 27903096
    [No Abstract]   [Full Text] [Related]  

  • 19. Pregabalin for the treatment of generalized anxiety disorder.
    Wensel TM; Powe KW; Cates ME
    Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early improvement with pregabalin predicts endpoint response in patients with generalized anxiety disorder: an integrated and predictive data analysis.
    Montgomery SA; Lyndon G; Almas M; Whalen E; Prieto R
    Int Clin Psychopharmacol; 2017 Jan; 32(1):41-48. PubMed ID: 27583543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.